BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38308097)

  • 21. Nrf2 and Her3 co-expression in cholangiocarcinoma: Possible biological pathways for potential therapeutic approach.
    Parente P; Angerilli V; Zamboni G; Sparaneo A; Fiordelisi F; Di Candia L; Fassan M; Graziano P
    Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):317-321. PubMed ID: 36882359
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
    Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
    Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939.
    Wang JB; Liu LX; Pan SH; Wang CY; Fu QF
    Neoplasma; 2010; 57(1):79-85. PubMed ID: 19895177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of a chlorophyll derivative and investigation of its photodynamic activities against cholangiocarcinoma.
    Wu ZM; Wang L; Zhu W; Gao YH; Wu HM; Wang M; Hu TS; Yan YJ; Chen ZL
    Biomed Pharmacother; 2017 Aug; 92():285-292. PubMed ID: 28551549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells.
    Lee HM; Jeong YI; Kim DH; Kwak TW; Chung CW; Kim CH; Kang DH
    Int J Pharm; 2013 Sep; 454(1):74-81. PubMed ID: 23834828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic Therapy using Talaporfin Sodium for the Recurrence of Cholangiocarcinoma after Surgical Resection.
    Shimizu S; Nakazawa T; Hayashi K; Naitoh I; Miyabe K; Kondo H; Nishi Y; Umemura S; Hori Y; Kato A; Morisaki T; Nanashima A; Ohara H; Joh T
    Intern Med; 2015; 54(18):2321-6. PubMed ID: 26370855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy in cholangiocarcinoma.
    Kahaleh M
    J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S44-7. PubMed ID: 23055215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma.
    Kiesslich T; Wolkersdörfer G; Neureiter D; Salmhofer H; Berr F
    Photochem Photobiol Sci; 2009 Jan; 8(1):23-30. PubMed ID: 19247524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.
    Nanashima A; Yamaguchi H; Shibasaki S; Ide N; Sawai T; Tsuji T; Hidaka S; Sumida Y; Nakagoe T; Nagayasu T
    J Gastroenterol; 2004 Nov; 39(11):1095-101. PubMed ID: 15580404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
    Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
    Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of whole cell-derived vesicular delivery systems for photodynamic therapy of extrahepatic cholangiocarcinoma.
    Li M; Bosman EDC; Smith OM; Lintern N; de Klerk DJ; Sun H; Cheng S; Pan W; Storm G; Khaled YS; Heger M;
    J Photochem Photobiol B; 2024 May; 254():112903. PubMed ID: 38608335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-Responsive Multifunctional Nanoplatform Based on Peptide Self-Assembly for Highly Efficient Combined Cancer Therapy by Alleviating Hypoxia and Improving the Immunosuppressive Microenvironment.
    Wu J; Liu Y; Cao M; Zheng N; Ma H; Ye X; Yang N; Liu Z; Liao W; Sun L
    ACS Appl Mater Interfaces; 2023 Feb; 15(4):5667-5678. PubMed ID: 36651290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damage.
    Yu TT; Hu J; Li QR; Peng XC; Xu HZ; Han N; Li LG; Yang XX; Xu X; Yang ZY; Chen H; Chen X; Wang MF; Li TF
    Int Immunopharmacol; 2023 Feb; 115():109661. PubMed ID: 36608440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Molecular Pathogenesis and Targeted Therapies for Cholangiocarcinoma.
    Param NJ; Bramel ER; Sia D
    Surg Pathol Clin; 2022 Sep; 15(3):529-539. PubMed ID: 36049834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
    Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
    Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymeric photosensitizer-embedded self-expanding metal stent for repeatable endoscopic photodynamic therapy of cholangiocarcinoma.
    Bae BC; Yang SG; Jeong S; Lee DH; Na K; Kim JM; Costamagna G; Kozarek RA; Isayama H; Deviere J; Seo DW; Nageshwar Reddy D
    Biomaterials; 2014 Oct; 35(30):8487-95. PubMed ID: 25043500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses.
    Xia T; Li K; Niu N; Shao Y; Ding D; Thomas DL; Jing H; Fujiwara K; Hu H; Osipov A; Yuan C; Wolfgang CL; Thompson ED; Anders RA; He J; Mou Y; Murphy AG; Zheng L
    J Hematol Oncol; 2022 Mar; 15(1):37. PubMed ID: 35346322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of percutaneous transhepatic cholangioscopy-guided photodynamic therapy for postoperative recurrent extrahepatic cholangiocarcinoma.
    Chen Z; Jiang X; Xue P; Chen S; Li S; Li Z; Pan W; Zhang D
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103122. PubMed ID: 36115558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells.
    Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan V
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):601-12. PubMed ID: 25708948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
    Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
    Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.